Form 8-K BIOGEN INC. For: Oct 14
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/23/2026
- Wall St falls as tech earnings spark AI spending worries and oil hits $100
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Google increases capex forecast again after cloud-driven quarterly beat
- As Musk pivots beyond cars, Tesla’s autos engine is under strain
- RTX stock jumps as company lifts guidance after Q2 beat
Biogen expects $2 million charge in third quarter 2025
October 14, 2025 4:21 PM EDTBiogen Inc. (NASDAQ: BIIB) announced it expects approximately $2 million in acquired in-process research and development, upfront and milestone expenses on a pre-tax basis for the third quarter of 2025.
The biotechnology company said the estimated charge will impact both GAAP and non-GAAP net income... More
